[Therapeutic Response and Prognosis of Adult Acute Myeloid Leukemia with Chromosome Karyotype Abnormalities]. 2019

Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
Department of Hematology, The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, Huai'an 223300, Jiangsu Province, China;Key Laboratory of Hematology of Nanjing Medical University, Nanjing 210029, Jiangsu Province, China.

OBJECTIVE To investigate the efficacy and prognosis of acute myeloid leukemia (AML) patients with chromosome karyotype abnormalities. METHODS The clinical features and treatment responses of 91 patients with AML were collected and analyzed retrospectively. The efficacy and survival rate of the AML patients with normal and abnormal chromosome karyotype were compared. RESULTS Chromosome translocations and monosomal karyotypes were the main heterogeneity of AML. There was no significant difference in complete remission rate and overall response rate between the normal and abnormal karyotype groups, but the recurrence rate was higher in abnormal karyotype group. There was no significant difference in response of AML patients received the standard "3+7 regimen" and pre-excitation chemotherapy in the treatment of normal and abnormal karyotype groups. The relapse free survival time (RFS) was longer in the normal karyotype group, but there was no significant difference in overall survival time (OS). CONCLUSIONS The abnormal karyotype of AML is an independent prognostic factor, monosomal karyotype shows a poor prognosis, and the recurrence rate in AML patients with monosomal karyotype is higher.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D059785 Karyotype The full set of CHROMOSOMES presented as a systematized array of METAPHASE chromosomes from a photomicrograph of a single CELL NUCLEUS arranged in pairs in descending order of size and according to the position of the CENTROMERE. (From Stedman, 25th ed) Karyotypes

Related Publications

Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
November 2019, Leukemia,
Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
January 2016, Blood cancer journal,
Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
March 2008, Leukemia & lymphoma,
Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
January 2008, Vestnik Rossiiskoi akademii meditsinskikh nauk,
Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
May 1993, Cancer genetics and cytogenetics,
Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
February 2009, Zhongguo shi yan xue ye xue za zhi,
Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
March 1998, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
April 2001, Haematologica,
Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
June 1992, Nihon rinsho. Japanese journal of clinical medicine,
Yue Chen, and Shan-Dong Tao, and Yu-Ye Shi, and Li-Xiao Song, and Yuan Deng, and Lan-Lan Ling, and Bang-He Ding, and Kan-Kan Chen, and Zheng-Mei He, and Chun-Ling Wang, and Liang Yu
August 1991, Acta paediatrica Japonica : Overseas edition,
Copied contents to your clipboard!